The HIV-1 cell entry inhibitor T-20 potently chemoattracts neutrophils by specifically activating the N-formylpeptide receptor

Biochemical and Biophysical Research Communications

Volumn 272, Issue 3, 2000, Pages 699-704

  Hartt, Jennifer K ^a   Liang, Thomas ^a   Sahagun Ruiz, Alfredo ^a   Wang, Ji Ming ^b   Gao, Ji Liang ^a   Murphy, Philip M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

AIDS HIV; Chemotaxis; G protein coupled receptor; Inflammation; Neutrophil

Indexed keywords

CALCIUM; CELL RECEPTOR; ENFUVIRTIDE; FORMYLPEPTIDE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; EMBRYO; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLAMMATION; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; VIRUS ADSORPTION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0034674332     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2846     Document Type: Article

References (26)

1. Willey R. L., Bonifacino J. S., Potts B. J., Martin M. A., Klausner R. D. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. Proc. Natl. Acad. Sci. USA. 85:1988;9580.
2. Kowalski M., Potz J., Basiripour L., Dorfman T., Goh W. C., Terwilliger E., Dayton A., Rosen C., Haseltine W., Sodroski J. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science. 237:1987;1351.
3. Dimitrov D. S., Broder C. C. Receptor-mediated HIV entry. HIV and Membrane Receptors. 1997;Landes BioscienceMedical Intelligence Unit, Austin. p. 124.
4. Chan D. C., Fass D. J., Berger M., Kim P. S. Core structure of gp41 from the HIV envelope glycoprotein. Cell. 89:1997;263.
5. Freed E. O., Myers D. J., Risser R. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc. Natl. Acad. Sci. USA. 87:1990;4650.
6. Lawless M. K., Barney S., Guthrie K. I., Bucy T. B., Petteway S. R. Jr., Merutka G. HIV-1 membrane fusion mechanism: Structural studies of the interactions between biologically-active peptides from gp41. Biochemistry. 35:1996;13697.
7. Ueda H., Howard O. M. Z., Grimm M. C., Su S. B., Gong W., Evans G., Ruscetti F. W., Oppenheim J. J., Wang J. M. HIV-1 envelope gp41 is a potent inhibitor of chemoattractant receptor expression and function in monocytes. J. Clin. Invest. 102:1998;804.
8. Rimsky L. T., Shugars D. C., Matthews T. J. Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides. J. Virol. 72:1998;986.
9. Wild C. T., Greenwell T. K., Matthews T. J. A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion. AIDS Res. Hum. Retroviruses. 9:1993;1051.
10. Wild C. T., Shugars D. C., Greenwell T. K., McDanal C. B., Matthews T. J. Peptides corresponding to a predictive alpha-helical domain of HIV-1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA. 91:1994;9770.
11. Kilby J. M., Hopkins S., Venetta T. M., DiMassimo B., Cloud G. A., Lee J. Y., Alldredge L., Hunter E., Lambert D., Bolognesi D., Matthews T., Johnson M. R., Nowak M. A., Shaw G. M., Saag M. S. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat. Med. 4:1998;1302.
12. Pilcher C. D., Eron J. J. Jr., Ngo L., Dusek A., Sista P., Gleavy J., Brooks D., Venetta T., DiMassimo E., Hopkins S. Prolonged therapy with the fusion inhibitor T-20 in combination with oral antiretroviral agents in an HIV-infected individual. AIDS. 13:1999;2171.
13. Chan D. C., Kim P. S. HIV entry and its inhibition. Cell. 93:1998;681.
14. Su S. B., Gong W., Gao J.-L., Shen W., Grimm M. C., Deng X., Murphy P. M., Oppenheim J. J., Wang J. M. T-20/DP178, an ectodomain peptide of human immunodeficiency virus type 1 gp41, is an activator of human phagocyte N-formyl peptide receptor. Blood. 93:1999;3885.
15. Su S. B., Gao J.-L., Gong W., Dunlop N. M., Murphy P. M., Oppenheim J. J., Wang J. M. T21/DP107, a synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G protein-coupled formyl peptide receptors. J. Immunol. 162:1999;5924.
16. Murphy P. M. The N-formylpeptide chemotactic receptor. Horuk R. Chemoattractant Ligands and Their Receptors. 1996;269 CRC Press, Boca Raton.
17. Murphy P. M. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12:1994;593.
18. Boulay F., Tardif M., Brouchon L., Vignais P. The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors. Biochemistry. 29:1990;11123.
19. Fiore S., Maddox J. F., Perez H. D., Serhan C. N. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J. Exp. Med. 180:1994;253.
20. Su S. B., Gong W., Gao J.-L., Shen W., Murphy P. M., Oppenheim J. J., Wang J. M. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189:1999;395.
21. Gao J.-L., Chen H., Filie J. D., Kozak C. A., Murphy P. M. Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse. Genomics. 51:1998;270.
22. Gao J.-L., Murphy P. M. Species and subtype variants of the N-formyl peptide chemotactic receptor reveal multiple important functional domains. J. Biol. Chem. 268:1993;25395.
23. Hartt J. K., Barish G., Murphy P. M., Gao J.-L. N-formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N-formylpeptide receptor (FPR) subtypes: molecular characterization of FPR2, a second mouse neutrophil FPR. J. Exp. Med. 190:1999;741.
24. Gao J.-L., Lee E. J., Murphy P. M. Impaired anti-bacterial host defense in mice lacking the N-formylpeptide receptor. J. Exp. Med. 189:1999;657.
25. Durstin M., Gao J.-L., Tiffany H. L., McDermott D., Murphy P. M. Differential expression of the members of the N-formylpeptide receptor gene cluster in human phagocytes. Biochem. Biophys. Res. Commun. 201:1994;174.
26. Takano T., Fiore S., Maddox J. F., Brady H. R., Petasis N. A., Serhan C. N. Aspirin-triggered 15-epi-lipoxin A(4) (LXA(4)) and LXA(4) stable analogues are potent inhibitors of acute inflammation: Evidence for anti-inflammatory receptors. J. Exp. Med. 185:1997;1693.